Canadian Cancer Trials Group Bulletins

Group Administrators Office


UPDATE -- Canadian Cancer Trials Group Young Investigator Awards

The Canadian Cancer Trials Group's Central Operations and Statistics Office is very pleased to announce that we have updated the criteria and extended the deadline for the Recognition Awards noted below. The Young Investigator awards now allow for nominees within 7 years of certification (rather than 3 years) to better capture the development of investigators during the early stage of their careers.

Dr. Ralph Meyer Phase III Young Investigator Award
The Ralph Meyer Young Investigator Award is presented annually to any MD, fellow, PhD, within 7 years of certification / appointment or current fellow who has either spent time at Canadian Cancer Trials Group's Central Office, worked on Phase III projects with Disease Site Committees / Endpoint Committees / Working Groups, or who has contributed significantly to the conduct of a Phase III trial at a centre.

Dr. Elizabeth Eisenhauer Early Drug Development Young Investigator Award
The Elizabeth Eisenhauer Young Investigator Award is presented annually to any MD, fellow, or PhD, within 7 years of certification / appointment, or current fellow who has either spent time at Canadian Cancer Trials Group's Central Office, worked on projects with the Investigational New Drug Program or who has contributed significantly to the conduct of an IND trial at a centre.

All nominations should be sent to Alison Urton, Group Administrator, at aurton@ctg.queensu.ca by Friday, March 27th, 2015. For complete information, including the nomination process, please see this link ... http://www.ctg.queensu.ca/public/awards/awards.html.